The Board considered and approved issue of warrants subject to the approval of Shareholder vide special resolution.

Halder Venture Limited's board, at its meeting on 26 March 2026, approved the issuance of up to 7,93,650 convertible warrants at ₹315 per warrant (face value ₹10 + premium ₹305), totalling about ₹24.99 crore, on a preferential basis to a single non-promoter entity, P.K. Bio Link Private Limited. Each warrant is convertible into one equity share of the company. The board also approved increasing the authorised share capital from ₹13.42 crore to ₹18.42 crore (adding 50 lakh new equity shares of ₹10 each) to accommodate the potential conversion, along with a corresponding amendment to the Memorandum of Association. All these actions are subject to shareholder approval through a postal ballot, the notice for which was also approved. Separately, the internal auditor M/s Somnath Ray & Associates resigned citing increased professional commitments, and M/s J Kumar Jain & Associates was appointed as the new internal auditor for FY25-26.